What does Telomir Pharmaceuticals, Inc. do?
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against…
What is Telomir Pharmaceuticals, Inc.'s P/E and P/B ratio?
Telomir Pharmaceuticals, Inc. has a P/E ratio of -0.9 and a P/B ratio of 14.77.
What is Telomir Pharmaceuticals, Inc.'s debt-to-equity ratio?
Telomir Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.03.
How much does Telomir Pharmaceuticals, Inc. owe compared with what it owns?
Telomir Pharmaceuticals, Inc. owes $0.06 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Telomir Pharmaceuticals, Inc.'s Positivity rank?
Telomir Pharmaceuticals, Inc. is ranked #5,962 of 6,774 companies globally and #3,352 of 4,000 in United States on PositoAI, with a Positivity Score of 13,309.
Does Telomir Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. Telomir Pharmaceuticals, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 12 Jan 2026). It has no yellow flags.
Where can I read the latest news about Telomir Pharmaceuticals, Inc.?
Recent headlines about Telomir Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Telomir Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Telomir Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.